Peter W Szlosarek

6PUBLICATIONS
23CO-AUTHORS
Molecular targetsHaematological tumoursGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 20, 2026
Pegargiminase Suppresses the Fanconi Anemia Pathway and Promotes Melphalan-Induced DNA Double-Strand Breaks in Uveal Melanoma.

|Jan 14, 2026
Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient Cohort.

George Nassief, Tolulope Adeyelu, Andrew Elliott

|May 17, 2023
Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma.

Melissa M Phillips, Iuliia Pavlyk, Michael Allen

|Apr 03, 2023
A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma.

Melissa M Phillips, Iuliia Pavlyk, Michael Allen

|Jan 20, 2023
BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification.

Sarah E Barnett, Jenna Kenyani, Martina Tripari

|Aug 12, 2021
Phase 1, pharmacogenomic, dose-expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer.

Peter W Szlosarek, Akhila G Wimalasingham, Melissa M Phillips

Pageof 1

Frequent Collaborators

1 joint publications

Sarah E Barnett

1 joint publications

Jenna Kenyani

1 joint publications

Martina Tripari

1 joint publications

Zohra Butt